The Food and Drug Administration holds a meeting Thursday to decide whether a daily pill called Truvada should be approved for people who are at risk of contracting HIV. A positive review posted Tuesday suggests the pill will become the first drug approved to prevent HIV infection in healthy patients.
Thursday's discussion is likely to focus on which patients should take the drug. The FDA will ask a panel of outside experts to vote on whether Truvada should be approved for:
_ gay and bisexual men
_ men or women in relationships with HIV-positive partners
_ other people at risk of acquiring HIV through sexual activity
The FDA is not required to follow the advice of its panels, though it usually does. A final decision on the drug is expected by June 15.
Wife of US Pastor Held in Iran: 'I Never Thought I’d Have to Battle My Own Gov't For My Husband’s Freedom' | Leah Barkoukis
Politifact: On Second Thought, Obama's 'Keep Your Plan' Pledge is 2013's 'Lie of the Year' | Guy Benson
Conservatives Clash as House Prepares to Vote on Ryan-Murray Budget Deal -- UPDATE: House passes 332-94 | Guy Benson
New White House Push: Sign Up For Obamacare Because It Will Give Your Mother "Piece of Mind" | Daniel Doherty
Heartbreaking: Dad Gives Up Trying to Obtain Health Insurance For His Ailing Son on the Exchanges | Daniel Doherty